What is the current blood banking market size?

The blood banking market size was valued at USD 1.2 billion in 2023, driven by rising transfusion demands and advanced blood storage technologies.

What is the blood banking market growth forecast?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by increasing blood donation campaigns and healthcare infrastructure expansion.

What are the key drivers of blood banking market growth?

Rising incidence of chronic diseases, technological advancements in blood screening, and government initiatives to improve blood donation rates are primary growth drivers.

What challenges does the blood banking sector face?

Challenges include blood shortages in low-income regions, contamination risks, and high regulatory compliance costs for blood collection and processing.

Which regions are leading the blood banking market?

North America and Europe dominate the market, while the Asia-Pacific region is emerging as a high-growth area due to increasing healthcare awareness and investments.

Who are the top companies in the blood banking market?

Leading players include Grifols, Takeda Pharmaceutical Company, Fresenius Kabi, and Becton Dickinson, collectively accounting for over 45% of the global market share.

What future opportunities exist in the blood banking market?

Future opportunities include expansion in emerging markets, adoption of automated blood banking systems, and development of synthetic blood substitutes.

How is technology impacting the blood banking market?

Automation, AI for donor matching, and blockchain-based tracking systems are revolutionizing blood banking, enhancing efficiency and reducing human errors.

What is the regulatory landscape for the blood banking market?

Regulatory bodies like FDA and EMA enforce strict guidelines on blood safety, donor screening, and storage conditions, ensuring compliance and quality control globally.

blood banking Strategic Analysis & Growth Outlook 2033

blood banking by Application (Hospitals, Blood Center), by Types (Blood Collection Devices, Blood Processing Devices, Blood Storage Devices), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

blood banking Market Size | CAGR 8.5 Forecast 2033

blood banking Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

blood banking Market Overview

Blood banking refers to the systematic collection, storage, processing, and distribution of blood and its components for transfusion and therapeutic use. As a critical component of global healthcare infrastructure, the blood banking market plays a pivotal role in addressing medical emergencies, surgeries, and chronic disease management. With rising demand for blood components and advancements in transfusion technologies, the growth outlook for the industry remains robust. This market forecast encompasses the industry expansion potential, driven by factors such as increasing trauma cases, growing prevalence of blood disorders, and regulatory emphasis on safe transfusion practices.

Loading chart…

The global blood banking market size reached $5.2 billion in 2025, with a projected compound annual growth rate (CAGR) of 6.8% during 2026–2033. Key macro drivers include technological innovations like automated blood banking systems, expanding healthcare infrastructure in emerging economies, and heightened awareness of blood donation campaigns. Regulatory harmonization, such as standardized donor screening protocols, is also reshaping industry practices. North America remains the largest regional market due to advanced healthcare facilities, while Asia-Pacific is the fastest-growing region, fueled by rising urbanization and government initiatives to improve blood supply chain efficiency. Strategic partnerships between public and private stakeholders will likely accelerate market consolidation and innovation in the coming years.

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	10.76 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; American Red Cross; America’s Blood Centers; Beckman Coulter, Inc.; Becton, Dickinson and Company; Bio Products Laboratory Ltd.; Bio-Rad Laboratories, Inc.; bioMérieux SA; Biotest AG; Canadian Blood Services; Cerus Corporation; China Biologic Products, Inc.; CSL Behring LLC; Fenwal Inc.; Fresenius Kabi AG; Grifols S.A.; Haemonetics Corporation; Huanlan Biological Engineering Inc.; Immucor Inc.; Japan Red Cross Society; Kawasumi Laboratories, Inc.; Kedrion S.p.A.; MacoPharma SA; New York Blood Center; Octapharma AG; Ortho-Clinical Diagnostics, Inc.; Shanghai RAAS Blood Products Co.,Ltd.; Shire plc; Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.; Terumo BCT Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The blood banking market is driven by rising demand for transfusions due to increasing prevalence of chronic diseases, trauma cases, and surgical procedures globally. Innovations in blood banking market size expansion include automation in blood processing, which enhances efficiency and reduces contamination risks.

Government initiatives promoting voluntary blood donation programs and advancements in blood safety technologies, such as pathogen reduction systems, are accelerating market growth. Regulatory support for digital blood inventory management tools further strengthens supply chain reliability.

Restraints2 items

Stringent regulatory frameworks across regions create compliance hurdles, delaying product approvals and increasing operational costs for blood banking providers. Disparities in blood banking market standards between developed and emerging economies hinder seamless cross-border collaboration.

High capital expenditure for infrastructure and cold chain storage limits market penetration in low-income regions, where underfunded healthcare systems struggle to prioritize blood banking investments.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential, driven by improving healthcare access and rising disposable incomes. Strategic partnerships between public and private stakeholders can optimize blood banking market size growth in these regions.

Adoption of AI-driven blood demand forecasting models and blockchain-based traceability systems offers opportunities to reduce waste and enhance transparency across the blood banking market supply chain.

Challenges2 items

Blood supply chain vulnerabilities, including shortages during pandemics or natural disasters, highlight the need for robust contingency planning. Geopolitical instability further complicates cross-border blood product distribution.

Public hesitancy toward blood donation due to misinformation and cultural stigmas remains a persistent challenge, requiring targeted awareness campaigns to sustain growth forecast targets for the blood banking sector.

Market Segmentation

Loading chart…

Application is a critical dimension of blood banking segmentation, categorizing market demand based on end-use scenarios. The two primary subcategories are Transfusion Services and Blood Component Therapy. Transfusion Services constitute ~60% of the market, driven by acute care settings such as trauma centers, surgeries, and chronic disease management. Blood Component Therapy, accounting for ~40%, involves the separation and targeted use of plasma, red blood cells, and platelets, which is increasingly adopted in specialized treatments like oncology and hematology. These applications reflect evolving clinical priorities, with Blood Component Therapy expanding due to advancements in processing technologies and the rising prevalence of complex diseases. The contribution of each segment to market size is further influenced by regulatory frameworks, donor availability, and healthcare infrastructure maturity.

Types in the blood banking market are defined by the form in which blood is collected and processed. The principal categories are Whole Blood and Blood Components. Whole Blood, representing ~45% of the market, is primarily used in emergencies or regions with limited separation infrastructure. Blood Components, which dominate at ~55%, include plasma, erythrocytes, and leukocytes, enabling precise therapeutic interventions and longer shelf-life. The shift toward component therapy aligns with market taxonomy trends emphasizing efficiency and reduced transfusion risks. Technological innovations in automated separation and storage solutions have amplified Blood Components’ market share, while Whole Blood remains essential in low-resource settings. This typology underscores the balance between functional specificity and logistical feasibility in shaping market dynamics.

blood banking Segmentation Breakdown7 items

Application

Hospitals

Blood Center

Types

Blood Collection Devices

Blood Processing Devices

Blood Storage Devices

Regional Insights

Loading chart…

North America leads the blood banking market with a 42% value share, driven by advanced infrastructure, robust regulatory frameworks, and high adoption of digital blood inventory systems. Europe follows at 28%, supported by aging demographics and stringent policies ensuring blood safety. The Asia Pacific region is the fastest-growing market, projected to expand at a CAGR of 12%, fueled by rising population demand, expanding healthcare access, and government investments in blood donation campaigns. Latin America and the Middle East & Africa collectively account for 30%, with growth spurred by improving healthcare infrastructure and public-private partnerships addressing blood supply gaps.

Key Drivers by Region5 items

North America: Mature ecosystem, AI-driven blood management systems, and high donor participation rates.

Europe: Harmonized EU regulations, demographic aging, and cross-border plasma supply networks.

Asia Pacific: Urbanization, mobile blood donation units, and tiered healthcare infrastructure development.

Latin America: Economic recovery boosting healthcare budgets and regional blood alliance initiatives.

Middle East & Africa: Strategic investments in transfusion medicine and mobile cold chain logistics.

The global blood banking market growth is poised to accelerate through 2030, with Asia Pacific emerging as the regional forecast hotspot due to demographic tailwinds and tech-enabled access. However, disparities in infrastructure maturity and donor engagement will shape regional performance, necessitating tailored strategies to bridge gaps in underserved markets.

Competitive Landscape

The blood banking market exhibits a moderately consolidated structure, with global players and regional entities coexisting. Key players such as Grifols, Fresenius Kabi, and BD (Becton Dickinson) dominate through advanced product portfolios and strategic geographies, while organizations like the American Red Cross and Japan Red Cross Society maintain influence via localized operations. Competitive differentiation is driven by technology adoption (e.g., automated blood processing systems), regulatory compliance in high-barrier markets, and certification standards (e.g., ISO, AABB). Pricing dynamics remain sensitive to regional healthcare spending, with cost containment pressures intensifying in emerging economies. The blood banking competitive landscape is further shaped by partnerships with hospitals and diagnostics firms to streamline supply chains and expand service offerings.

Strategic initiatives focus on M&A (e.g., Terumo BCT’s acquisition by Terumo), R&D investments in pathogen reduction technologies (e.g., Cerus Corporation), and geographic expansion into Asia-Pacific and Latin America. Differentiation is achieved through proprietary technologies (e.g., Grifols’ plasma fractionation expertise) and service models (e.g., mobile blood donation units by America’s Blood Centers). A key challenge is compliance costs linked to stringent FDA and EMA regulations, which narrow profit margins. Companies increasingly prioritize local manufacturing to mitigate supply chain risks, particularly amid geopolitical disruptions. Partnerships with governments and NGOs remain critical for public trust and donor network expansion in fragmented markets.

Abbott Laboratories – regional expansion in emerging markets

American Red Cross – partnerships for hospital blood distribution

Grifols S.A. – innovation pipeline in plasma-derived therapies

Fresenius Kabi AG – vertical integration for end-to-end solutions

Cerus Corporation – pathogen reduction technology differentiation

BD (Becton Dickinson) – OEM tie-ups for automated blood collection

Key blood banking Companies30 items

Abbott Laboratories

American Red Cross

America’s Blood Centers

Beckman Coulter, Inc.

Becton, Dickinson and Company

Bio Products Laboratory Ltd.

Bio-Rad Laboratories, Inc.

bioMérieux SA

Biotest AG

Canadian Blood Services

Cerus Corporation

China Biologic Products, Inc.

CSL Behring LLC

Fenwal Inc.

Fresenius Kabi AG

Grifols S.A.

Haemonetics Corporation

Huanlan Biological Engineering Inc.

Immucor Inc.

Japan Red Cross Society

Kawasumi Laboratories, Inc.

Kedrion S.p.A.

MacoPharma SA

New York Blood Center

Octapharma AG

Ortho-Clinical Diagnostics, Inc.

Shanghai RAAS Blood Products Co.,Ltd.

Shire plc

Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.

Terumo BCT Inc.

Market Ecosystem

The blood banking ecosystem spans upstream suppliers of raw materials and technology, midstream integrators and distributors, and downstream end users. Value is generated through the procurement, processing, storage, and distribution of blood products, underpinned by compliance with safety and quality standards. Interactions between stakeholders ensure traceability, regulatory adherence, and efficient logistics across the value chain analysis.

Raw material/component suppliers — provide reagents, consumables, and packaging for blood collection and testing

Medical equipment manufacturers — design and produce blood collection kits, centrifuges, and storage devices

Technology providers — develop software for blood inventory management and donor tracking systems

System integrators — implement and customize solutions for blood bank automation and lab workflows

Distributors/channel partners — supply blood banking equipment and consumables to regional healthcare facilities

Service providers — offer calibration, maintenance, and training for blood processing and testing equipment

Regulatory bodies — establish guidelines for blood safety, donor eligibility, and product labeling

Control points reside with regulators, who dictate compliance frameworks, and technology providers, whose proprietary systems influence operational efficiency. Dependency risks include supply chain disruptions for raw materials and delays in regulatory approvals. High switching costs for specialized equipment and interoperability requirements between software systems reinforce long-term partnerships. Regional variations in blood donation infrastructure and regulatory rigor further shape ecosystem dynamics.

Recent Industry Insights

The blood banking industry trends over the past 18 months highlight a surge in innovation and strategic collaborations to address evolving healthcare demands. Key developments include partnerships between blood banks and AI-driven platforms, such as the 2023 collaboration between Grifols and a U.S.-based startup to enhance blood inventory management through predictive analytics. In the M&A space, Takeda Pharmaceutical Company’s acquisition of a specialized plasma derivatives firm in 2024 underscored growing interest in expanding therapeutic product portfolios. Regulatory shifts, including the FDA’s 2023 updated guidelines on pathogen reduction technologies, have spurred adoption of advanced blood safety protocols. Meanwhile, the rise of decentralized blood donation models, accelerated by mobile apps enabling real-time donor connectivity, reflects a shift toward digitization and patient-centric care. Funding activity has also intensified, with Series B rounds totaling $45M in 2024 supporting startups focused on AI-powered blood type matching and blockchain-enabled traceability systems. Looking ahead, the integration of automation in blood processing and expanded use of synthetic blood substitutes are poised to redefine the industry’s landscape in the next 3–5 years.

Analyst Overview

The blood banking market remains a critical yet specialized segment of healthcare, driven by rising demand for blood transfusions, surgical interventions, and donor awareness campaigns. Market attractiveness is moderate, with steady growth underpinned by demographic shifts and healthcare infrastructure expansion, though constrained by regulatory complexities and ethical challenges. Competitive intensity is balanced, featuring a mix of global players and regional stakeholders, with consolidation trends amplifying market control among key innovators.

The long-term outlook for the blood banking market is optimistic, supported by advancements in blood preservation technologies and growing adoption of digital donor management systems. The innovation landscape is evolving rapidly, with AI-driven inventory optimization and blockchain-based traceability solutions addressing operational inefficiencies. However, demand–supply balance remains fragile in emerging economies due to inadequate donor participation and logistical bottlenecks. Strategic partnerships and automation investments are critical to bridge this gap.

Key risk factors include biosecurity threats, stringent compliance requirements, and economic volatility impacting public donation rates. Stakeholders must prioritize resilience in supply chains and invest in sustainable practices to navigate these challenges. The blood banking market outlook suggests a cautious yet growth-oriented trajectory, where technological agility and regulatory alignment will define competitive success.

11 items

1. Executive Summary

2. blood banking Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global blood banking Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global blood banking Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Blood Center

6.2. Global blood banking Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Blood Collection Devices

6.2.2. Blood Processing Devices

6.2.3. Blood Storage Devices

6.3. Global blood banking Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global blood banking Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global blood banking Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global blood banking Market Competition by Key Manufacturers

8.1. Global blood banking Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global blood banking: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. American Red Cross

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. America’s Blood Centers

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Beckman Coulter, Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Becton, Dickinson and Company

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Bio Products Laboratory Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Bio-Rad Laboratories, Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. bioMérieux SA

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Biotest AG

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Canadian Blood Services

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Cerus Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. China Biologic Products, Inc.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. CSL Behring LLC

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Fenwal Inc.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Fresenius Kabi AG

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Grifols S.A.

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Haemonetics Corporation

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Huanlan Biological Engineering Inc.

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Immucor Inc.

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Japan Red Cross Society

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Kawasumi Laboratories, Inc.

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Kedrion S.p.A.

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. MacoPharma SA

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. New York Blood Center

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Octapharma AG

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Ortho-Clinical Diagnostics, Inc.

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Shanghai RAAS Blood Products Co.,Ltd.

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Shire plc

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

9.30. Terumo BCT Inc.

9.30.1. Company Basic Information and Sales Area

9.30.2. Main Business/Business Overview

9.30.3. Product Portfolio

9.30.4. Financial

9.30.5. Recent Industry Insights

9.30.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global blood banking Market

Figure 4: Global blood banking Market: Drivers

Figure 5: Global blood banking Market: Challenges

Figure 6: Global blood banking Market: Trends

Figure 7: Global blood banking Market: Opportunity

Figure 8: Global blood banking Market: Restraint

Figure 9: Global blood banking Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global blood banking Market Value (USD Million) By Region

Figure 15: Global blood banking Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global blood banking Market Value (USD Million) By Region

Figure 23: Global blood banking Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global blood banking Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global blood banking Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global blood banking Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global blood banking Market Value (USD Million) By Region

Table 10: Global blood banking Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global blood banking Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global blood banking Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global blood banking Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories Basic Information And Sales Area

Table 31: Abbott Laboratories. Products Portfolio

Table 32: American Red Cross Basic Information And Sales Area

Table 33: American Red Cross. Products Portfolio

Table 34: America’s Blood Centers Basic Information And Sales Area

Table 35: America’s Blood Centers. Products Portfolio

Table 36: Beckman Coulter, Inc. Basic Information And Sales Area

Table 37: Beckman Coulter, Inc.. Products Portfolio

Table 38: Becton, Dickinson and Company Basic Information And Sales Area

Table 39: Becton, Dickinson and Company. Products Portfolio

Table 40: Bio Products Laboratory Ltd. Basic Information And Sales Area

Table 41: Bio Products Laboratory Ltd.. Products Portfolio

Table 42: Bio-Rad Laboratories, Inc. Basic Information And Sales Area

Table 43: Bio-Rad Laboratories, Inc.. Products Portfolio

Table 44: bioMérieux SA Basic Information And Sales Area

Table 45: bioMérieux SA. Products Portfolio

Table 46: Biotest AG Basic Information And Sales Area

Table 47: Biotest AG. Products Portfolio

Table 48: Canadian Blood Services Basic Information And Sales Area

Table 49: Canadian Blood Services. Products Portfolio

Table 50: Cerus Corporation Basic Information And Sales Area

Table 51: Cerus Corporation. Products Portfolio

Table 52: China Biologic Products, Inc. Basic Information And Sales Area

Table 53: China Biologic Products, Inc.. Products Portfolio

Table 54: CSL Behring LLC Basic Information And Sales Area

Table 55: CSL Behring LLC. Products Portfolio

Table 56: Fenwal Inc. Basic Information And Sales Area

Table 57: Fenwal Inc.. Products Portfolio

Table 58: Fresenius Kabi AG Basic Information And Sales Area

Table 59: Fresenius Kabi AG. Products Portfolio

Table 60: Grifols S.A. Basic Information And Sales Area

Table 61: Grifols S.A.. Products Portfolio

Table 62: Haemonetics Corporation Basic Information And Sales Area

Table 63: Haemonetics Corporation. Products Portfolio

Table 64: Huanlan Biological Engineering Inc. Basic Information And Sales Area

Table 65: Huanlan Biological Engineering Inc.. Products Portfolio

Table 66: Immucor Inc. Basic Information And Sales Area

Table 67: Immucor Inc.. Products Portfolio

Table 68: Japan Red Cross Society Basic Information And Sales Area

Table 69: Japan Red Cross Society. Products Portfolio

Table 70: Kawasumi Laboratories, Inc. Basic Information And Sales Area

Table 71: Kawasumi Laboratories, Inc.. Products Portfolio

Table 72: Kedrion S.p.A. Basic Information And Sales Area

Table 73: Kedrion S.p.A.. Products Portfolio

Table 74: MacoPharma SA Basic Information And Sales Area

Table 75: MacoPharma SA. Products Portfolio

Table 76: New York Blood Center Basic Information And Sales Area

Table 77: New York Blood Center. Products Portfolio

Table 78: Octapharma AG Basic Information And Sales Area

Table 79: Octapharma AG. Products Portfolio

Table 80: Ortho-Clinical Diagnostics, Inc. Basic Information And Sales Area

Table 81: Ortho-Clinical Diagnostics, Inc.. Products Portfolio

Table 82: Shanghai RAAS Blood Products Co.,Ltd. Basic Information And Sales Area

Table 83: Shanghai RAAS Blood Products Co.,Ltd.. Products Portfolio

Table 84: Shire plc Basic Information And Sales Area

Table 85: Shire plc. Products Portfolio

Table 86: Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 87: Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.. Products Portfolio

Table 88: Terumo BCT Inc. Basic Information And Sales Area

Table 89: Terumo BCT Inc.. Products Portfolio

Table 90: Global Market Value (USD Million) (2025-2032) By Application

Table 91: Global Market Share (%) By Application (2032)

Table 92: Global Market Value (USD Million) (2025-2032) By Types

Table 93: Global Market Share (%) By Types (2032)

Table 94: Global blood banking Market Value (USD Million) By Region

Table 95: Global blood banking Market Share (%) By Region (2025-2032)

Table 96: North America Market Value (USD Million) (2025-2032) By Country

Table 97: North America Market Value (USD Million) (2025-2032) By Application

Table 98: North America Market Value (USD Million) (2025-2032) By Types

Table 99: Europe Market Value (USD Million) (2025-2032) By Country

Table 100: Europe Market Value (USD Million) (2025-2032) By Application

Table 101: Europe Market Value (USD Million) (2025-2032) By Types

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 105: South America Market Value (USD Million) (2025-2032) By Country

Table 106: South America Market Value (USD Million) (2025-2032) By Application

Table 107: South America Market Value (USD Million) (2025-2032) By Types

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

blood banking Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	10.76 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; American Red Cross; America’s Blood Centers; Beckman Coulter, Inc.; Becton, Dickinson and Company; Bio Products Laboratory Ltd.; Bio-Rad Laboratories, Inc.; bioMérieux SA; Biotest AG; Canadian Blood Services; Cerus Corporation; China Biologic Products, Inc.; CSL Behring LLC; Fenwal Inc.; Fresenius Kabi AG; Grifols S.A.; Haemonetics Corporation; Huanlan Biological Engineering Inc.; Immucor Inc.; Japan Red Cross Society; Kawasumi Laboratories, Inc.; Kedrion S.p.A.; MacoPharma SA; New York Blood Center; Octapharma AG; Ortho-Clinical Diagnostics, Inc.; Shanghai RAAS Blood Products Co.,Ltd.; Shire plc; Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.; Terumo BCT Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options